A full pharmacological analysis of the three Turkey β-adrenoceptors and comparison with the human β-adrenoceptors

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Baker, Jillian G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ALKALINE PHOSPHATASE PLACENTA ISOENZYME; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 3C ADRENERGIC RECEPTOR; BETA 4C ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; TRITIUM; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPROTEIN; PROPANOLAMINE DERIVATIVE; PROPRANOLOL;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ADHESION; CONTROLLED STUDY; ENZYME SYNTHESIS; LIGAND BINDING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RECEPTOR BINDING; SPECIES DIFFERENCE; ANIMAL; BINDING COMPETITION; CHO CELL; COMPARATIVE STUDY; CRICETULUS; DOSE RESPONSE; DRUG EFFECT; GENETICS; HAMSTER; HUMAN; METABOLISM; MOLECULAR GENETICS; MUTATION; RADIOASSAY; SEQUENCE HOMOLOGY; TURKEY (REPUBLIC);

AVES; MAMMALIA; RATTUS;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROPANOLAMINES; PROPRANOLOL; PROTEIN ISOFORMS; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, BETA; SEQUENCE HOMOLOGY, AMINO ACID; TRITIUM; TURKEY;

EID: 78649775608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015487     Document Type: Article

References (43)

1. Pak MD, Fishman PH (1996) Anomalous behaviour of CGP 12177A on beta 1-adrenergic receptors. J Recept Signal Transduction Res 16: 1-23.
2. Granneman JG (2001) The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor. Am J Physiol Endocrinol Metab 280: E199-202.
3. Molenaar P (2003) The 'state' of beta-adrenoceptors. Br J Pharmacol 140: 1-2.
4. Arch JR (2004) Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine? Br J Pharmacol 143: 517-518.
5. Kaumann AJ, Molenaar P (2008) The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacology. Pharmacol Ther 118: 303-336.
6. Konkar AA, Zhu Z, Granneman JG (2000) Aryloxypropanolamine and catecholamine ligand interactions with the β1-adrenergic receptor: evidence for interaction with distinct conformations of β1-adrenergic receptors. J Pharmacol Exp Ther 294: 923-932.
7. Lowe MD, Lynham JA, Grace AA, Kaumann AJ (2002) Comparison of the affinity of β-blockers for the two states of the β1-adrenoceptor in ferret ventricular myocardium. Br J Pharmacol 135: 451-461.
8. Sarsero D, Russell FD, Lynham JA, Rabnott G, Yang I, et al. (2003) (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol 367: 10-21.
9. Baker JG (2005) Sites of action of β-ligands at the human β1-adrenoceptor. J Pharmacol Exp Ther 313: 1163-1171.
10. Walter M, Lemoine H, Kaumann AJ (1984) Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn Schmiedebergs Arch Pharmacol 327: 159-175.
11. Baker JG, Hall IP, Hill SJ (2003) Agonist actions of ''β-blockers'' provide evidence for two agonist activation sites or conformations of the human β1-adrenoceptor. Mol Pharmacol 63: 1312-1321.
12. Joseph SS, Lynham JA, Colledge WH, Kaumann AJ (2004) Binding of (-)-[3H]- CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers. Naunyn Schmiedebergs Arch Pharmacol 369: 525-532.
13. Baker JG, Proudman RGW, Hawley NC, Fischer PM, Hill SJ (2008) Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human β1-adrenoceptor. Mol Pharmacol 74: 1246-1260.
14. Baker JG (2005) Evidence for a secondary state of the human β3-adrenoceptor. Mol Pharmacol 68: 1645-1655.
15. Oye I, Sutherland EW (1996) The effect of epinephrine and other agents on adenyl cyclase in the cell membrane of avian erythrocytes. Biochim Biophys Acta 127: 347-54.
16. Schramm M, Feinstein H, Naim E, Lang E, Lasser M (1972) Epinephrine binding to the catecholamine receptor and activation of the adenylate cyclase in erythrocyte membranes (hormone receptor- -adrenergic receptor-cyclic AMPturkey). Proc Natl Acad Sci U S A 69: 523-7.
17. Bilezikian JP, Aurbach GD (1973) A beta-adrenergic receptor of the turkey erythrocyte. I. Binding of catecholamine and relationship to adenylate cyclase activity. J Biol Chem 248: 5577-83.
18. Bilezikian JP, Aurbach GD (1973) A beta-adrenergic receptor of the turkey erythrocyte. II. Characterization and solubilization of the receptor. J Biol Chem 248: 5584-9.
19. Chen XH, Harden TK, Nicholas RA (1994) Molecular cloning and characterization of a novel beta-adrenergic receptor. J Biol Chem 269: 24810-9.
20. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, et al. (2007) High resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318: 1258-1265.
21. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, et al. (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450: 383-7.
22. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, et al. (2007) GPCR Engineering yields high-resolution structural insights into β2- adrenergic receptor function. Science 318: 1266-1273.
23. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, et al. (2008) Structure of a β1-adrenergic G-protein coupled receptor. Nature 454: 486-491.
24. Baker JG, Hall IP, Hill SJ (2002) Pharmacological characterization of CGP 12177 at the human β2-adrenoceptor. Br J Pharmacol 137: 400-408.
25. Baker JG (2005) The selectivity of β-adrenoceptor antagonists at the β1, β2 and β3 adrenoceptors. Br J Pharmacol 144: 317-322.
26. Donaldson J, Brown AM, Hill SJ (1988) Influence of rolipram on the cyclic-3',5'- adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex. Biochem Pharmacol 37: 715-723.
27. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14: 48-58.
28. Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11: 5109-5116.
29. Baker JG, Hall IP, Hill SJ (2003) Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: Differences between second messenger and reporter gene responses. Mol Pharmacol 64: 679-688.
30. Baker JG (2010) The selectivity of β-adrenoceptor agonists at the human β1, β2 and β3 adrenoceptors. Br J Pharmacol 160: 1048-1061.
31. Kenakin TP, Bond RA, Bonner TI (1992) Definition of pharmacological receptors. Pharmacol Rev 44: 351-362.
32. Nishimura J, Kanaide H, Nakamura M (1987) Characteristics of adrenoceptors and [3H]nitrendipine receptors of porcine vascular smooth muscle: differences between coronary artery and aorta. Circ Res 60: 837-844.
33. Goepel M, Wittmann A, Rübben H, Michel MC (1997) Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol Res 1997; 25(3): 199-206.
34. Liang W, Mills S (2001) Profile of ligand binding to the porcine beta2-adrenergic receptor. J Anim Sci 79: 877-83.
35. Konkar AA, Zhai Y, Granneman JG (2000) Beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol 57: 252-258.
36. Lewis CJ, Gong H, Brown MJ, Harding SE (2004) Overexpression of beta 1- adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for 'putative' beta 4-adrenoceptor pharmacology. Br J Pharmacol 141: 813-24.
37. Kozlowska H, Szymska U, Schlicker E, Malinowska B (2003) Atypical betaadrenoceptors, different from beta 3-adrenoceptors and probably from the lowaffinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery. Br J Pharmacol 140: 3-12.
38. Cohen ML, Bloomquist W, Ito M, Lowell BB (2000) Beta3 receptors mediate relaxation in stomach fundus whereas a fourth beta receptor mediates tachycardia in atria from transgenic beta3 receptor knockout mice. Receptor Channels 7: 17-23.
39. Kaumann AJ, Engelhardt S, Hein L, Molenaar P, Lohse M (2001) Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn Schmiedebergs Arch Pharmacol 363: 87-93.
40. Kaumann AJ, Molenaar P (1997) Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 355: 667-681.
41. Azzi M, Charest PG, Angers S, Rosseau G, Kohout T, et al. (2003) Betaarrestin- mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 100: 11406-11.
42. Baker JG, Hall IP, Hill SJ (2003) Agonist and inverse agonist actions of ''βblockers'' at the human β2-adrenoceptor provide evidence for agonist-directed signalling. Mol Pharmacol 64: 1357-1369.
43. Hutchinson DS, Sato M, Evans BA, Christopoulos A, Summers RJ (2005) Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]- 2S-2-propanol oxalate]. J Pharmacol Exp Ther 312: 1064-74.